Particle.news

Download on the App Store

Zee Entertainment Outlines Oversight for ₹2,237 Crore Promoter Infusion Before Vote

Zee Entertainment has outlined fund usage timing alongside SEBI-monitored oversight for its ₹2,237 crore promoter infusion ahead of shareholder voting

Image
Image
Image
Image

Overview

  • Zee’s board approved the preferential allotment of 16.95 crore fully convertible warrants at ₹132 each to promoter entities for a total infusion of ₹2,237 crore.
  • Upon conversion of the warrants, promoter shareholding through Altilis Technologies and Sunbright Mauritius will rise from 3.99 percent to 18.39 percent.
  • Subhash Chandra and management clarified that the funds derive from promoter-linked recoveries without any loans or share pledges and will be injected promptly rather than spread over 18 months.
  • The company will deploy a SEBI-registered monitoring agency to oversee fund utilisation aimed at strengthening the balance sheet and supporting content and digital-technology initiatives.
  • Three domestic proxy advisors — SES, IiAS and InGovern Research — have recommended voting against the proposal on grounds of dilution risk and insufficient project-wise use-of-proceeds details ahead of voting from July 6 to July 9.